The Food and Drugs Authority (FDA) has cautioned consumers to exercise extreme caution when purchasing palm oil due to ongoing concerns about adulteration. This warning comes in light of the FDA’s continued efforts to combat the presence of hazardous substances, specifically the notorious ‘Sudan Four’ dye, which has been detected in some palm oil products circulating on the market.
The presence of this industrial dye, which is banned for use in food products due to its carcinogenic properties, poses a serious health risk to consumers. Roderick Daddey-Adjei, the Deputy Chief Executive Officer of the FDA, expressed deep concern over the persistence of this issue, despite the Authority’s rigorous enforcement actions.
He acknowledged the progress made in reducing the prevalence of adulterated palm oil but emphasised that even a small percentage of contamination remains unacceptable.
